Budd-Chiari syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 8: Line 8:


==Laboratory Findings==
==Laboratory Findings==
When Budd-Chiari syndrome is suspected, measurements are made of
When Budd-Chiari syndrome is suspected, measurements are made of :


* [[Liver enzyme]] levels
* [[Liver enzyme]] levels
Line 17: Line 17:
* [[Liver biopsy]] is nonspecific but sometimes necessary to differentiate between Budd-Chiari syndrome and other causes of hepatomegaly and ascites, such as [[galactosemia]] or [[Reye's syndrome]]
* [[Liver biopsy]] is nonspecific but sometimes necessary to differentiate between Budd-Chiari syndrome and other causes of hepatomegaly and ascites, such as [[galactosemia]] or [[Reye's syndrome]]
* Severe hepatic [[necrosis]] and [[lactic acidosis]] may be present as well.  Caudate lobe hypertrophy is often present. The majority of patients have a slower-onset form of Budd-Chiari syndrome. This can be painless.  Patients may progress to [[cirrhosis]] and show the signs of liver failure.
* Severe hepatic [[necrosis]] and [[lactic acidosis]] may be present as well.  Caudate lobe hypertrophy is often present. The majority of patients have a slower-onset form of Budd-Chiari syndrome. This can be painless.  Patients may progress to [[cirrhosis]] and show the signs of liver failure.
*Laboratory findings consistent with the diagnosis of acute and fulminant BCS include:
**Elevated Serum aspartate and alanine aminotransferase levels may be more than five times the upper limit of the normal range.
**Elevated Serum alkaline phosphatase and bilirubin levels, decreased serum albumin level.
**Ascitic fluid examination shows:
**Total protein level more than 2.5 g per deciliter
**White blood cells are usually less than 500/μL.
**Additional Hematological tests are recommended to evaluate for hypercoagulability.


==References==
==References==

Revision as of 19:10, 6 November 2017

Budd-Chiari syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Budd-Chiari syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Budd-Chiari syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Budd-Chiari syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Budd-Chiari syndrome laboratory findings

CDC on Budd-Chiari syndrome laboratory findings

Budd-Chiari syndrome laboratory findings in the news

Blogs on Budd-Chiari syndrome laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Budd-Chiari syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Laboratory Findings

When Budd-Chiari syndrome is suspected, measurements are made of :

  • Laboratory findings consistent with the diagnosis of acute and fulminant BCS include:
    • Elevated Serum aspartate and alanine aminotransferase levels may be more than five times the upper limit of the normal range.
    • Elevated Serum alkaline phosphatase and bilirubin levels, decreased serum albumin level.
    • Ascitic fluid examination shows:
    • Total protein level more than 2.5 g per deciliter
    • White blood cells are usually less than 500/μL.
    • Additional Hematological tests are recommended to evaluate for hypercoagulability.

References